Strides Pharma corrects US time for Q4FY26 earnings call
Published on: May 18, 2026, 9:38 a.m. | Source: scanx.trade
Strides Pharma Science has corrected the US time for its Q4FY26 earnings call to 7:30 AM EDT, maintaining the original schedule of May 18, 2026. The board meeting will consider audited financial results and a potential final dividend. Management participants include Badree Komandur and Vikesh Kumar.
